226 related articles for article (PubMed ID: 8223761)
1. The arrhythmogenic substrate--diagnostic and therapeutic implications: hypertrophic cardiomyopathy.
Slade AK; Saumarez RC; McKenna WJ
Eur Heart J; 1993 Sep; 14 Suppl E():84-90. PubMed ID: 8223761
[TBL] [Abstract][Full Text] [Related]
2. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Slade AK; Camm AJ
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():37-49. PubMed ID: 8734163
[TBL] [Abstract][Full Text] [Related]
3. Sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ; Fananapazir L
Circulation; 1992 Jan; 85(1 Suppl):I57-63. PubMed ID: 1728506
[TBL] [Abstract][Full Text] [Related]
4. Ventricular arrhythmias complicating hypertrophic cardiomyopathy.
Hutchings D; Sankaranarayanan R; Venetucci L
Br J Hosp Med (Lond); 2012 Sep; 73(9):502-8. PubMed ID: 23124402
[TBL] [Abstract][Full Text] [Related]
5. Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death.
Chang AC; McAreavey D; Fananapazir L
Curr Opin Cardiol; 1995 Jan; 10(1):9-15. PubMed ID: 7787270
[TBL] [Abstract][Full Text] [Related]
6. Neuro-cardiac interaction in malignant ventricular arrhythmia and sudden cardiac death.
Ng GA
Auton Neurosci; 2016 Aug; 199():66-79. PubMed ID: 27423297
[TBL] [Abstract][Full Text] [Related]
7. Arrhythmia and hypertrophic cardiomyopathy.
Shakespeare CF; Keeling PJ; Slade AK; McKenna WJ
Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():31-6. PubMed ID: 1307192
[TBL] [Abstract][Full Text] [Related]
8. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.
Adabag AS; Maron BJ
Ann Noninvasive Electrocardiol; 2007 Apr; 12(2):171-80. PubMed ID: 17593187
[No Abstract] [Full Text] [Related]
9. Remodeled left ventricular myocardium remote to infarction sites is the arrhythmogenic substrate for sudden cardiac death.
Tsai CF; Ueng KC; Wu DJ; Tsai TP; Lin CS
Med Hypotheses; 2010 Oct; 75(4):368-71. PubMed ID: 20399566
[TBL] [Abstract][Full Text] [Related]
10. Management of hypertrophic cardiomyopathy in children.
Seggewiss H; Rigopoulos A
Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
[TBL] [Abstract][Full Text] [Related]
11. Inducibility of life-threatening ventricular arrhythmias is related to maximum left ventricular thickness and clinical markers of sudden cardiac death in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
Hedman A; Hartikainen J; Vanninen E; Laitinen T; Jääskeläinen P; Laakso M; Peuhkurinen K; Kuusisto J
J Mol Cell Cardiol; 2004 Jan; 36(1):91-9. PubMed ID: 14734051
[TBL] [Abstract][Full Text] [Related]
12. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?].
Grobéty M; Schlaepfer J; Kappenberger L; Fromer M
Schweiz Med Wochenschr; 1997 Apr; 127(15):623-30. PubMed ID: 9198888
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics of cardiac arrhythmia in patients with hypertrophic cardiomyopathy].
Wang Y; Cui YH; Wang DW
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):401-4. PubMed ID: 15061995
[TBL] [Abstract][Full Text] [Related]
14. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
[TBL] [Abstract][Full Text] [Related]
15. Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia.
Wolf CM; Moskowitz IP; Arno S; Branco DM; Semsarian C; Bernstein SA; Peterson M; Maida M; Morley GE; Fishman G; Berul CI; Seidman CE; Seidman JG
Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18123-8. PubMed ID: 16332958
[TBL] [Abstract][Full Text] [Related]
16. Syncope and ventricular arrhythmias in hypertrophic cardiomyopathy are not related to the derangement of coronary microvascular function.
Lorenzoni R; Gistri R; Cecchi F; Olivotto I; Chiriatti G; Elliott P; McKenna WJ; Camici PG
Eur Heart J; 1997 Dec; 18(12):1946-50. PubMed ID: 9447323
[TBL] [Abstract][Full Text] [Related]
17. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
[No Abstract] [Full Text] [Related]
18. Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy.
Maron BJ; Cecchi F; McKenna WJ
Br Heart J; 1994 Dec; 72(6 Suppl):S13-8. PubMed ID: 7873317
[No Abstract] [Full Text] [Related]
19. Sudden unexpected death in young athletes: reconsidering "hypertrophic cardiomyopathy".
Rowland T
Pediatrics; 2009 Apr; 123(4):1217-22. PubMed ID: 19336382
[TBL] [Abstract][Full Text] [Related]
20. Baseline fragmented QRS increases the risk of major arrhythmic events in hypertrophic cardiomyopathy: Systematic review and meta-analysis.
Rattanawong P; Riangwiwat T; Kanitsoraphan C; Chongsathidkiet P; Kanjanahattakij N; Vutthikraivit W; Chung EH
Ann Noninvasive Electrocardiol; 2018 Jul; 23(4):e12533. PubMed ID: 29363882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
